Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea
A Prospective, Controlled Trial of Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea of Prematurity
Sponsor: Manitoba Institute of Child Health
Terminated
Low recruitment rate
Other terminated trials from Manitoba Institute of Child Health
More terminations from Manitoba Institute of Child Health
Other Apnea of Prematurity trials with similar outcome
Listed as NCT01911182, this PHASE2/PHASE3 trial focuses on Apnea of Prematurity and remains terminated or withdrawn. Sponsored by Manitoba Institute of Child Health, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE2_PHASE3
First recorded
Oct 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Manitoba Institute of Child Health
- University of Manitoba
For direct contact, visit the study record on ClinicalTrials.gov .